Module 4: Acute harms and management of SCRAs and hallucinogens

by Dr Dima Abdulrahim, Dr David Wood, Dr Sarah Finlay and Dr Owen Bowden-Jones, on behalf of the NEPTUNE group


Published: September 2017


This module is aimed at clinicians who are likely to come into contact with people presenting to hospital with acute harms resulting from the use of novel psychoactive substances (NPS) and club drugs.


Specifically, this module provides learning about the acute harms of synthetic cannabinoid receptor agonists (SCRAs) and hallucinogens, and the management of such harms.


Start the module


© 2021 NEPTUNE